Suppr超能文献

GWAS 随访研究食管鳞癌发现与上消化道癌家族史相关的潜在遗传位点。

GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer.

机构信息

Henan Key Laboratory for Esophageal Cancer Research, The First Affiliated Hospital of Zhengzhou University, 40 Daxue Road, Zhengzhou, Henan, 450052, P.R. China.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.

出版信息

Sci Rep. 2017 Jul 5;7(1):4642. doi: 10.1038/s41598-017-04822-2.

Abstract

Based on our initial genome-wide association study (GWAS) on esophageal squamous cell carcinoma (ESCC) in Han Chinese, we conducted a follow-up study to examine the single nucleotide polymorphisms (SNPs) associated with family history (FH) of upper gastrointestinal cancer (UGI) cancer in cases with ESCC. We evaluated the association between SNPs and FH of UGI cancer among ESCC cases in a stage-1 case-only analysis of the National Cancer Institute (NCI, 541 cases with FH and 1399 without FH) and Henan GWAS (493 cases with FH and 869 without FH) data (discovery phase). The top SNPs (or their surrogates) from discovery were advanced to a stage-2 evaluation in additional Henan subjects (2801 cases with FH and 3136 without FH, replication phase). A total of 19 SNPs were associated with FH of UGI cancer in ESCC cases with P < 10 in the stage-1 meta-analysis of NCI and Henan GWAS data. In stage-2, the association for rs79747906 (located at 18p11.31, P = 5.79 × 10 in discovery) was replicated (P = 0.006), with a pooled-OR of 1.59 (95%CI: 1.11-2.28). We identified potential genetic variants associated with FH of UGI cancer. Our findings may provide important insights into new low-penetrance susceptibility regions involved in the susceptibility of families with multiple UGI cancer cases.

摘要

基于我们在中国汉族人群中进行的食管鳞状细胞癌(ESCC)全基因组关联研究(GWAS),我们进行了一项后续研究,以检验与 ESCC 患者上消化道癌家族史(FH)相关的单核苷酸多态性(SNP)。我们在国家癌症研究所(NCI,541 例有 FH 和 1399 例无 FH)和河南 GWAS(493 例有 FH 和 869 例无 FH)数据的病例对照分析的 1 期阶段(病例组)中评估了 SNP 与 ESCC 患者 FH 之间的关联(发现阶段)。来自发现阶段的顶级 SNP(或其替代物)在河南的额外受试者中进行了 2 期评估(2801 例有 FH 和 3136 例无 FH,复制阶段)。在 NCI 和河南 GWAS 数据的 1 期荟萃分析中,共有 19 个 SNP 与 ESCC 患者的 UGI 癌症 FH 相关,P 值均小于 10。在 2 期阶段,rs79747906(位于 18p11.31 上,发现时 P = 5.79×10)的关联得到了复制(P = 0.006),合并 OR 为 1.59(95%CI:1.11-2.28)。我们鉴定了与 UGI 癌症 FH 相关的潜在遗传变异。我们的研究结果可能为多例 UGI 癌症家族易感性相关的新低外显率易感区域提供重要的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验